Events Partner Content 3rd Annual Computational Drug Development (CDD) for Biologic... CDD for Biologics | 13-15 November 2018 | Boston, USA
Views & Analysis Artificial intelligence in drug discovery and diagnosis Machine learning is widely predicted to make drug discovery and patient diagnosis quicker, cheaper and more effective in the future, and signs of this can already be seen.
Events Partner Content IMPACCT:RWE - Real-World Evidence Conference, Boston 2018 Real-World Evidence Conference
Partner Content Partner Content FDA releases Biosimilar Action Plan: Hear more at Biosimilar... Biosimilars USA conference information
Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.